Home Search Abstracts Browse Sessions Program Committee Conference Webcasts Contact Us

 

 


 

Session 142  Poster Abstracts
Renal and Bone Abnormalities
Thursday, 1:30 - 3:30 pm
Hall B
      818

Chronic Kidney Disease and the Use of HAART
Ronald Reisler*1, L Jacobson2, S Gupta3, W Qiao2, J Margolick2, S Riddler4, B Visscher5, C Williams6, and F Palella7
1Inst of Human Virology, Univ of Maryland, Baltimore, USA; 2Johns Hopkins Univ, Bloomberg Sch of Publ Hlth, Baltimore, MD, USA; 3Indiana Univ Sch of Med, Indianapolis, USA; 4Univ of Pittsburgh Grad Sch of Publ Hlth, PA, USA; 5Univ of California, Los Angeles, Sch of Publ Hlth, USA; 6DAIDS, NIAID, NIH, DHHS, Bethesda, MD, USA; and 7Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA
      819

Beyond Serum Creatinine: Identification of Renal Insufficiency Using Gglomerular Filtration: Implications for Clinical Research and Care
Stephen Becker*1, R Balu2, and J Fusco2
1Pacific Horizon Med Group, San Francisco, CA, USA and 2GlaxoSmithKline, Research Triangle Park, NC, USA
      820

Decline in Renal Function Associated with Tenofovir DF Compared with Nucleoside Reverse Transcriptase Inhibitor Treatment
Joel Gallant*, M Parish, J Keruly, and R Moore
Johns Hopkins Univ Sch of Med, Baltimore, MD, USA
      821

HIV is Associated with Increased Prevalence of Microalbuminuria
L Szczech1, Carl Grunfeld*2,5, J Canchola3, S Sydney4, and M Shlipak2,5
1Duke Univ Med Ctr, Durham, NC, USA; 2Univ of California, San Francisco, USA; 3Univ of California, San Francisco, USA; 4Kaiser Northern California Div of Res, Oakland, USA; and 5San Francisco VA Med Ctr, CA, USA
      822 Pathophysiologic Correlates of RANKL Deregulation in HIV Infection and Its Therapy
Mohamad Fakruddin jamiluddin*1, M Yin2, and J Laurence3
1Weill Med Coll, Cornell Univ, New York, NY, USA; 2Columbia Univ Mailman Sch of Publ Hlth, New York, NY, USA; and 3Weill Med Coll, Cornell Univ, New York, NY, USA
      823

Similar Incidence of Osteopenia and Osteoporosis in ART-naïve Patients Treated with Tenofovir DF or Stavudine in Combination with Lamivudine and Efavirenz over 144 Weeks
William Powderly*1, C Cohen2, J Gallant3, B Lu4, J Enejosa4, A Cheng4, and Study 903 Team
1Univ Coll, Dublin, Ireland; 2Community Res Initiative New England, Boston, MA, USA; 3Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; and 4Gilead Sci, Foster City, CA, USA
      824 Serum Cholesterol Concentrations as well as Fasting Glycemia Is Associated with Decreased Bone Mineral Density and High Osteoblastic Activity in HIV-1-infected Patients
A Wiercinska-Drapalo, Jerzy Jaroszewicz*, E Tarasow, and D Prokopowicz
Med Univ of Bialystok, Poland
      825

Duration of ARTand Change in Bone Mineral Density over Time
Denise Jacobson*1, J Huang1, A Shevitz1,2, T Knox1, S Gorbach1,2, and D Spiegelman3
1Tufts Univ Sch of Med, Boston, MA, USA; 2Tufts-New England Med Ctr, Boston, MA, USA; and 3Harvard Sch of Publ Hlth, Boston, MA, USA